{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T07:38:59Z","timestamp":1789198739469,"version":"build-2803163510"},"reference-count":44,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[1999,8,1]],"date-time":"1999-08-01T00:00:00Z","timestamp":933465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[1999,8]]},"DOI":"10.1006\/nbdi.1999.0244","type":"journal-article","created":{"date-parts":[[2002,10,7]],"date-time":"2002-10-07T19:08:06Z","timestamp":1034017686000},"page":"259-268","source":"Crossref","is-referenced-by-count":36,"title":["Serial 1H-NMR Spectroscopy Study of Metabolic Impairment in Primates Chronically Treated with the Succinate Dehydrogenase Inhibitor 3-Nitropropionic Acid"],"prefix":"10.1006","volume":"6","author":[{"given":"Caroline","family":"Dautry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francoise","family":"Cond\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Brouillet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Mittoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.Flint","family":"Beal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Bloch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Hantraye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1006\/nbdi.1999.0244_RF1","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1212\/WNL.42.4.733","article-title":"Alternative excitotoxic hypotheses","volume":"42","author":"Albin","year":"1992","journal-title":"Neurology"},{"key":"10.1006\/nbdi.1999.0244_RF2","first-page":"507","article-title":"Prospectives for cell and gene therapy in Huntington's disease","volume":"117","author":"Bachoud-Levi","year":"1998","journal-title":"Prog. Brain Res."},{"key":"10.1006\/nbdi.1999.0244_RF3","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/nbm.1940060114","article-title":"Quantitation of proton NMR spectra of the human brain using tissue water as an internal concentration reference","volume":"6","author":"Barker","year":"1993","journal-title":"NMR Biomed."},{"key":"10.1006\/nbdi.1999.0244_RF4","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1097\/00001756-199605310-00014","article-title":"Inhibition of N-acetylaspartate production: Implications for 1H MRS studies in vivo","volume":"7","author":"Bates","year":"1996","journal-title":"NeuroReport"},{"key":"10.1006\/nbdi.1999.0244_RF5","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1006\/exnr.1993.1053","article-title":"Chronic intraastriatal dialytic administration of quinolinic acid produces selective neural degeneration","volume":"120","author":"Bazzett","year":"1993","journal-title":"Exp. Neurol."},{"key":"10.1006\/nbdi.1999.0244_RF6","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1006\/exnr.1995.1054","article-title":"Chronic administration of malonic acid produces selective neural degeneration and transient changes in calbindin immunoreactivity in rat striatum","volume":"134","author":"Bazzett","year":"1995","journal-title":"Exp. Neurol."},{"key":"10.1006\/nbdi.1999.0244_RF7","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0149-7634(89)80048-X","article-title":"N-acetyl-l-aspartic acid: A literature review of a compound prominent in 1H NMR spectroscopic studies of brain","volume":"13","author":"Birken","year":"1989","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1006\/nbdi.1999.0244_RF8","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1046\/j.1471-4159.1998.70020794.x","article-title":"Partial inhibition of brain succinate deshydrogenase by 3-nitropropionic acid is sufficient to initiate striatal degeneration in rat","volume":"70","author":"Brouillet","year":"1998","journal-title":"J. Neurochem."},{"key":"10.1006\/nbdi.1999.0244_RF9","doi-asserted-by":"crossref","first-page":"7105","DOI":"10.1073\/pnas.92.15.7105","article-title":"Chronic mitochondrial energy impairment produces selective striatal degeneration and abnormal choreiform movements in primates","volume":"92","author":"Brouillet","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/nbdi.1999.0244_RF10","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/00019052-199512000-00014","article-title":"Effects of chronic intoxication with MPTP and 3-nitropropionic acid in primates","volume":"8","author":"Brouillet","year":"1995","journal-title":"Curr. Opin. Neurol."},{"key":"10.1006\/nbdi.1999.0244_RF11","article-title":"Systemic administration of 3-nitropropionic acid in primates: correlation between MRI findings and symptomatology (Abstract No. 21:490)","author":"Brouillet","year":"1995","journal-title":"Society for Neuroscience"},{"key":"10.1006\/nbdi.1999.0244_RF12","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1159\/000112191","article-title":"N-acetyl-l-aspartate is a major source of acetyl groups for lipid synthesis during rat brain development","volume":"13","author":"Burri","year":"1991","journal-title":"Dev. Neurosci."},{"key":"10.1006\/nbdi.1999.0244_RF13","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0730-725X(93)90418-D","article-title":"In vivo quantification of brain metabolites by 1H-MRS using water as in internal standard","volume":"11","author":"Christiansen","year":"1993","journal-title":"Magn. Reson. Imaging"},{"key":"10.1006\/nbdi.1999.0244_RF14","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1111\/j.1471-4159.1966.tb10292.x","article-title":"Acetate metabolism in the nervous system. N-acetyl-l-aspartic acid and the biosynthesis of brain lipids","volume":"13","author":"D'Adamo","year":"1966","journal-title":"J. Neurochem."},{"key":"10.1006\/nbdi.1999.0244_RF15","unstructured":"Dautry, C, Mittoux, V, &, Hantraye, P. 1997, Caract\u00e9risation RMN des processus neurod\u00e9g\u00e9n\u00e9ratifs impliqu\u00e9s dans un mod\u00e8le exp\u00e9rimental de la maladie de Huntington d\u00e9velopp\u00e9 chez le singe (Poster No. G20:209). 3i\u00e8me Colloque de la Soci\u00e9t\u00e9 des Neurosciences."},{"key":"10.1006\/nbdi.1999.0244_RF16","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1016\/S0140-6736(94)92987-4","article-title":"Proton MRS in Huntington's disease","volume":"343","author":"Davie","year":"1994","journal-title":"Lancet"},{"key":"10.1006\/nbdi.1999.0244_RF17","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1002\/mrm.1910340511","article-title":"Reversible decreases in N-acetylaspartate after acute brain injury","volume":"34","author":"De Stefano","year":"1995","journal-title":"Magn. Reson. Med."},{"key":"10.1006\/nbdi.1999.0244_RF18","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/jcbfm.1994.48","article-title":"N-acetylaspartate as an in vivo marker of neuronal viability in kainate-induced status epilepticus: 1H magnetic resonance spectroscopic imaging","volume":"14","author":"Ebisu","year":"1994","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1006\/nbdi.1999.0244_RF19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/jmrb.1993.1055","article-title":"Absolute quantitation of water and metabolites in the human brain. I. Compartments and water","volume":"102","author":"Ernst","year":"1993","journal-title":"J. Magn. Reson. B"},{"key":"10.1006\/nbdi.1999.0244_RF20","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/nbm.1940040408","article-title":"On the N-acetyl methyl resonance in localised 1H NMR spectra of human brain","volume":"4","author":"Frahm","year":"1991","journal-title":"NMR Biomed."},{"key":"10.1006\/nbdi.1999.0244_RF21","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1136\/jnnp.62.1.27","article-title":"Decreased N-acetylaspartate\/choline ratio and increased lactate in the frontal lobe of patients with Huntington's disease: A proton magnetic resonance spectroscopy study","volume":"62","author":"Harms","year":"1997","journal-title":"Neurol. Neurosurg. Psychiat."},{"key":"10.1006\/nbdi.1999.0244_RF22","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1046\/j.1471-4159.1995.65031184.x","article-title":"Selective inhibition of the tricarboxilic acid cycle of GABAergic neurons with 3-nitropropionic acid in vivo","volume":"65","author":"Hassel","year":"1995","journal-title":"J. Neurochem."},{"key":"10.1006\/nbdi.1999.0244_RF23","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/nbm.1940080402","article-title":"In vivo quantitation of metabolite concentrations in the brain by means of proton MRS","volume":"8","author":"Henriksen","year":"1995","journal-title":"NMR Biomed."},{"key":"10.1006\/nbdi.1999.0244_RF24","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/mrm.1910330502","article-title":"Localized proton NMR spectroscopy in the striatum of patients with idiopathic Parkinson's disease: A multicenter pilot study","volume":"33","author":"Holshouser","year":"1995","journal-title":"Magn. Reson. Med."},{"key":"10.1006\/nbdi.1999.0244_RF25","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1212\/WNL.43.12.2689","article-title":"Evidence for impairment of energy metabolism in vivo in Huntington's disease using localized 1H NMR spectroscopy","volume":"43","author":"Jenkins","year":"1993","journal-title":"Neurology"},{"key":"10.1006\/nbdi.1999.0244_RF26","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1212\/WNL.50.5.1357","article-title":"1H NMR spectroscopy studies of Huntington's disease. Correlations with CAG repeat numbers","volume":"50","author":"Jenkins","year":"1998","journal-title":"Neurology"},{"key":"10.1006\/nbdi.1999.0244_RF27","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1056\/NEJM199509073331007","article-title":"Mitochondrial DNA and disease","volume":"333","author":"Johns","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1006\/nbdi.1999.0244_RF28","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/ana.410410206","article-title":"Energy metabolism defects in Huntington's disease and effects of coenzyme Q10","volume":"41","author":"Koroshetz","year":"1997","journal-title":"Ann. Neurol."},{"key":"10.1006\/nbdi.1999.0244_RF29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/jmrb.1993.1056","article-title":"Absolute quantitation of water and metabolites in the human brain. II Metabolite concentrations","volume":"102","author":"Kreis","year":"1993","journal-title":"J. Magn. Reson. B"},{"key":"10.1006\/nbdi.1999.0244_RF30","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/nbm.1940070506","article-title":"Decrease in brain choline-containing compounds following a short period of global ischemia in gerbils as detected by 1H NMR spectroscopy in vivo","volume":"7","author":"Kuhmonen","year":"1994","journal-title":"NMR Biomed."},{"key":"10.1006\/nbdi.1999.0244_RF31","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","article-title":"Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice","volume":"87","author":"Mangiarini","year":"1996","journal-title":"Cell"},{"key":"10.1006\/nbdi.1999.0244_RF32","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1148\/radiology.187.1.8451417","article-title":"Absolute concentrations of metabolites in the adult human in vivo: Quantification of localized proton MR spectra","volume":"187","author":"Michaelis","year":"1993","journal-title":"Radiology"},{"key":"10.1006\/nbdi.1999.0244_RF33","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/nbm.1940040203","article-title":"A review of chemical issues in 1H NMR spectroscopy: N-acetylaspartate, creatine and choline","volume":"4","author":"Miller","year":"1991","journal-title":"NMR Biomed."},{"key":"10.1006\/nbdi.1999.0244_RF34","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/mrm.1910320115","article-title":"Abnormal cerebral metabolite concentrations in patients with probable Alzheimer disease","volume":"32","author":"Moats","year":"1994","journal-title":"Magn. Reson. Med."},{"key":"10.1006\/nbdi.1999.0244_RF35","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1038\/nm0898-963","article-title":"Fetal striatal allografts reverse cognition deficits in a primate model of Huntington disease","volume":"4","author":"Palfi","year":"1998","journal-title":"Nature Med."},{"key":"10.1006\/nbdi.1999.0244_RF36","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1523\/JNEUROSCI.16-09-03019.1996","article-title":"Chronic 3-nitropropionic acid treatment in baboons replicates the cognitive and motor deficits of Huntington's Disease","volume":"16","author":"Palfi","year":"1996","journal-title":"J. Neurosci."},{"key":"10.1006\/nbdi.1999.0244_RF37","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0021-9258(18)65008-2","article-title":"Studies on the distribution of N-acetyl-l-aspartic acid in brain","volume":"224","author":"Tallan","year":"1956","journal-title":"J. Biol. Chem."},{"key":"10.1006\/nbdi.1999.0244_RF38","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/mds.870110209","article-title":"Proton magnetic resonance spectroscopy in Huntington's disease: Evidence in favour of the glutamate excitotoxicity theory","volume":"11","author":"Taylor-Robinson","year":"1996","journal-title":"Movement Disorders"},{"key":"10.1006\/nbdi.1999.0244_RF39","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/S0140-6736(94)90280-1","article-title":"Evidence for glutamate excitotoxicity in Huntington's disease with proton magnetic resonance spectroscopy","volume":"343","author":"Taylor-Robinson","year":"1994","journal-title":"Lancet"},{"key":"10.1006\/nbdi.1999.0244_RF40","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1111\/j.1471-4159.1985.tb07240.x","article-title":"N-acetylation of l-aspartate in the nervous system: Differential distribution of a specific enzyme","volume":"45","author":"Truckenmiller","year":"1985","journal-title":"J. Neurochem."},{"key":"10.1006\/nbdi.1999.0244_RF41","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1471-4159.1992.tb08875.x","article-title":"Specific expression of N-acetylaspartate in neurons, oligodendrocyte-type-2 astrocyte progenitors, and immature oligodendrocytes in vitro","volume":"59","author":"Urenjak","year":"1992","journal-title":"J. Neurochem."},{"key":"10.1006\/nbdi.1999.0244_RF42","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/nbm.1940080604","article-title":"T1 and T2 relaxation times of the major 1H-containing metabolites in rat brain after focal ischemia","volume":"8","author":"Van Der Toorn","year":"1995","journal-title":"NMR Biomed."},{"key":"10.1006\/nbdi.1999.0244_RF43","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0140-6736(95)91184-7","article-title":"Reversal of brain metabolic alterations with zidovudine detected by proton localised magnetic resonance spectroscopy","volume":"345","author":"Vion-Dury","year":"1994","journal-title":"Lancet"},{"key":"10.1006\/nbdi.1999.0244_RF44","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1126\/science.1533953","article-title":"Mitochondrial genetics: A paradigm for aging and degenerative diseases","volume":"256","author":"Wallace","year":"1992","journal-title":"Science"}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996199902449?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996199902449?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,5,3]],"date-time":"2021-05-03T09:24:56Z","timestamp":1620033896000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996199902449"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,8]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1999,8]]}},"alternative-id":["S0969996199902449"],"URL":"https:\/\/doi.org\/10.1006\/nbdi.1999.0244","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[1999,8]]}}}